HEARTMATE II LVAS
Report
- Report Number
- 2916596-2015-00298
- Event Type
- Injury
- Date Received
- February 18, 2015
- Date of Event
- December 10, 2014
- Report Date
- January 21, 2015
- Manufacturer
- THORATEC CORPORATION
- Product Code
- DSQ
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- NY, US
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
A ROOT CAUSE FOR THE PATIENT¿S GI BLEED COULD NOT BE DETERMINED THROUGH THIS EVALUATION. THE ACCOUNT COMMUNICATED THAT THE PATIENT WAS ADMITTED WITH DARK BLOODY STOOL AS WELL AS AN INTERNATIONAL NORMALIZED RATIO (INR) OF 4.2. AN ESOPHAGOGASTRODUODENOSCOPY (EGD) WAS PERFORMED AND THE PATIENT WAS TREATED WITH A 3 UNIT TRANSFUSION OF PACKED RED BLOOD CELLS. IT WAS FURTHER COMMUNICATED THAT THE PATIENT¿S PUMP WAS FUNCTIONING AS INTENDED. THE PATIENT WAS ULTIMATELY DISCHARGED ON (B)(6) 2014. A REVIEW OF DEVICE HISTORY RECORDS SHOWED NO DEVIATIONS FROM MANUFACTURING OR QA SPECIFICATIONS. NO FURTHER INFORMATION IS AVAILABLE. THE MANUFACTURER IS CLOSING ITS FILE ON THIS EVENT.
THE PATIENT WEIGHT WAS NOT AVAILABLE. APPROXIMATE AGE OF DEVICE - 11 MONTHS. NO FURTHER INFORMATION IS AVAILABLE AT THIS TIME. A SUPPLEMENTAL REPORT WILL BE SUBMITTED WHEN THE MANUFACTURER'S INVESTIGATION IS COMPLETED. PLACEHOLDER.
THE PATIENT WAS IMPLANTED WITH A LEFT VENTRICULAR ASSIST DEVICE (LVAD). IT WAS REPORTED THAT THE PATIENT PRESENTED TO THE HOSPITAL WITH DARK BLOODY STOOL. THE PATIENT'S INTERNATIONAL NORMALIZED RATIO VALUE WAS 4.2. THE PATIENT WAS DIAGNOSED WITH GI BLEEDING. AN ESOPHAGOGASTRODUODENOSCOPY (EGD) WAS PERFORMED; HOWEVER, THE RESULTS WERE NOT PROVIDED. THE PATIENT WAS TRANSFUSED WITH THREE UNITS OF PACKED RED BLOOD CELLS AND WAS DISCHARGED FROM THE HOSPITAL. THE LVAD WAS REPORTED TO BE FUNCTIONING AS INTENDED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 117092 | HEARTMATE II LVAS | LEFT VENTRICULAR ASSIST DEVICE | DSQ | THORATEC CORPORATION |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 63 YR | Required Intervention |